![]() |
市場調查報告書
商品編碼
1863649
全球醫用電池市場:按類型、電池類型、應用、最終用戶和地區劃分 - 市場規模、行業趨勢、機會分析和預測(2025-2033 年)Global Medical Battery Market: By Type, Battery Type, Application, End Users, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033 |
||||||
醫用電池市場是整個醫療保健產業中至關重要且快速成長的區隔市場。 2024 年,該市場規模約為 18.976 億美元,預計將實現顯著增長,到 2033 年達到 31.4657 億美元。預計 2025 年至 2033 年的複合年增長率 (CAGR) 為 5.78%。這一增長反映了可靠電源對於支援現代患者護理中必不可少的各種醫療設備的重要性日益增加。
醫療器材技術的進步進一步推動了醫用電池市場的成長。創新正在催生更緊湊、更有效率、更精密的醫療器械,從而提升其功能並改善患者預後。隨著這些設備變得越來越小巧、越來越精密,對能夠在不影響安全性和可靠性的前提下為複雜電子設備供電的高密度電池的需求日益增長。醫用電池必須符合嚴格的監管和安全標準,以確保在關鍵醫療環境中可靠運行,這使得醫用電池的研發和生產成為醫療技術領域的專業且至關重要環節。
全球醫用電池市場競爭異常激烈,前六名的公司(松下電器產業株式會社、Saft集團、GE醫療集團、Integer控股公司、金霸王電池和Maxell有限公司)佔了超過45%的總收入。這些公司憑藉著豐富的產品組合、技術創新和策略合作夥伴關係,奠定了堅實的基礎,成為各種醫療應用電池供應領域的領導者。
2025年10月,瓦爾塔股份公司在助聽器行業領先的盛會-2025年歐洲助聽器展(EUHA 2025)上展出了一系列用於助聽器和其他醫療應用的一次性電池和可充電電池。瓦爾塔的產品線涵蓋從標準電池到為特定醫療設備需求量身開發的專業解決方案。
2025年8月,一項重大進展發生:伊利卡公司(Ilika PLC)在美國馬薩諸塞州的合作工廠完成了最終認證階段,並開始生產固態微型電池。固態電池技術代表著一項重大進步,與傳統的鋰離子電池相比,它具有更高的安全性、更高的能量密度和更長的使用壽命等優勢。
除了產業進步之外,學術研究也在推動醫療電池技術的創新。 2025年7月,英國南威爾斯大學(USW)的研究人員宣布計畫開發可生物降解的電池,用於植入人體。這種電池採用可拉伸的超薄設計,能夠自然地隨人體移動,且不會造成不適或損傷。
核心成長因子
人工智慧 (AI) 與便攜式診斷設備的整合顯著提升了醫療電池市場對高性能電池的需求。這些先進設備利用複雜的演算法進行即時分析,即使在傳統臨床環境之外也能實現快速且準確的診斷。為了支援如此複雜的計算過程,這些設備需要高能量密度和持續可靠輸出的電源。隨著人工智慧驅動的醫療技術在醫療保健領域日益普及和重要,對滿足這些嚴格要求的電池的需求正在迅速增長。
新機會趨勢
得益於可攝入式電子設備及其高度微型化電源的顯著進步,體內診斷的尖端技術正在快速發展。這些創新的 "智慧藥丸" 代表了醫療技術的變革性飛躍,能夠對人體內部功能進行非侵入性、即時監測。而其運作的核心在於必須符合嚴格標準的電池。為了適應這些設備的緊湊外形,電池不僅必須極其小巧,而且必須極其安全可靠。此外,它們必須提供足夠的電力來運行複雜的感測機制和無線傳輸系統,同時保持最小的體積,以確保患者的舒適度和設備的有效性。
優化障礙
超級工廠(即大型電池製造設施)的建設延誤可能會阻礙醫療電池市場的成長。這些超級工廠對於滿足快速增長的高性能電池需求至關重要,尤其是鋰離子電池,它們為各種醫療設備提供動力。這些設施的開發延誤或停滯可能會在供應鏈中造成瓶頸,限制現有和新興醫療技術所需電池的供應。由於建造超級工廠需要大規模和複雜的技術,延誤通常源自於複雜的物流、財務和監管方面的挑戰。
The medical battery market represents a crucial and rapidly expanding segment within the broader healthcare industry. Valued at approximately US$ 1,897.60 million in 2024, this market is projected to grow significantly, reaching an estimated valuation of US$ 3,146.57 million by 2033. This anticipated growth corresponds to a compound annual growth rate (CAGR) of 5.78% over the forecast period from 2025 to 2033. Such expansion reflects the increasing importance of reliable power sources in supporting a wide array of medical devices that are essential for modern patient care.
Technological advancements in medical devices further fuel the growth of the medical battery market. Innovations have led to more compact, efficient, and sophisticated devices capable of delivering enhanced functionality and improved patient outcomes. As these devices become smaller and more feature-rich, the need for high-density batteries capable of powering complex electronics without compromising safety or reliability has intensified. Medical batteries must meet stringent regulatory and safety standards to ensure they perform reliably in critical healthcare settings, making their development and production a specialized and essential sector within healthcare technology.
The global medical battery market is characterized by intense competition, with the top six players-Panasonic Corporation, Saft Group, GE Healthcare, Integer Holdings Corporation, Duracell, and Maxell Ltd-collectively accounting for more than 45% of the total revenue share. These companies have established strong footholds through extensive product portfolios, technological innovation, and strategic partnerships, positioning themselves as leaders in supplying batteries for a range of medical applications.
In October 2025, Varta AG showcased its extensive portfolio of primary and rechargeable batteries for hearing aids and other medical applications at EUHA 2025, a leading event in the hearing aid industry. Varta's offerings span from standard battery cells to highly specialized, individually developed solutions tailored to specific medical device needs.
In a significant development in August 2025, Ilika PLC commenced production of its solid-state micro-batteries in the United States after completing the final qualification stage at a partner facility in Massachusetts. Solid-state battery technology represents a major step forward, offering advantages such as increased safety, higher energy density, and longer lifespan compared to traditional lithium-ion batteries.
In addition to industry advancements, academic research is also driving innovation in medical battery technology. In July 2025, researchers at the University of South Wales (USW) in the UK announced plans to develop biodegradable batteries designed specifically for implantation in the human body. These batteries are engineered to be stretchable and ultra-thin, enabling them to move naturally with the body's movements without causing discomfort or damage.
Core Growth Drivers
The integration of artificial intelligence (AI) into portable diagnostic tools is driving a notable surge in demand for high-performance batteries within the medical battery market. These advanced devices rely on sophisticated algorithms to conduct real-time analysis, enabling faster and more accurate diagnostics outside traditional clinical settings. To support such complex computational tasks, these tools require power sources that combine high energy density with the ability to deliver sustained, reliable output. The demand for batteries that can meet these rigorous requirements is rapidly increasing as AI-enabled medical technologies become more widespread and essential in healthcare.
Emerging Opportunity Trends
The frontier of internal diagnostics is rapidly evolving, propelled by significant advancements in ingestible electronics and the increasingly sophisticated miniaturized power sources that support them. These innovative "smart pills" represent a transformative leap in medical technology, enabling non-invasive, real-time monitoring of internal bodily functions. Central to their operation are batteries that must meet exacting standards-not only must they be incredibly small to fit within the compact form factors of these devices, but they also need to be exceptionally safe and reliable. Additionally, these batteries must supply sufficient power to run complex sensing mechanisms and wireless transmission systems, all while maintaining a minimal footprint to ensure patient comfort and device efficacy.
Barriers to Optimization
Delays in the construction of gigafactories, which are large-scale battery manufacturing facilities, have the potential to hamper the growth of the medical battery market. These gigafactories are critical to meeting the rapidly increasing demand for high-performance batteries, particularly lithium-ion batteries that power a wide range of medical devices. When the development of such facilities is postponed or slowed, it creates bottlenecks in the supply chain that can restrict the availability of batteries necessary for both existing and emerging medical technologies. The scale and sophistication required for gigafactory construction mean that any delays often result from complex logistical, financial, and regulatory challenges.
By Battery Type, the lithium-ion battery segment holds a commanding position in the medical battery market, capturing an impressive 50.73% share. This dominance is fundamentally driven by the superior technological attributes that lithium-ion batteries offer compared to other battery types. One of the most critical advantages is their high energy density, which typically ranges between 150 and 250 watt-hours per kilogram (Wh/kg). This high energy density enables medical device manufacturers to design smaller, more compact, and lightweight products without compromising on battery life or performance. In medical applications, where device portability and patient comfort are paramount, the ability to reduce size and weight while maintaining power capacity is a significant benefit.
By Type, the non-implantable medical devices battery segment commands the largest share in the medical battery market, accounting for 56.60% of the total. This leading position is largely due to the vast volume and diverse range of portable and wearable medical devices that rely on battery power in today's healthcare landscape. Unlike implantable devices, non-implantable medical devices encompass a broad spectrum of equipment used in hospitals, clinics, and increasingly in home and remote care settings. Their widespread adoption across multiple healthcare environments drives substantial demand for reliable, high-performance batteries.
By Application, the implantable medical devices segment exhibits remarkable market strength, commanding the largest share of 46.33% within the medical battery market. This dominant position is closely tied to the critical and life-sustaining functions that implantable devices perform, which in turn impose exceptionally stringent requirements on their power sources. Because these devices operate inside the human body, their batteries must deliver reliable, long-lasting energy to ensure continuous functionality without frequent interventions, making battery performance a matter of patient safety and quality of life.
By End Users, the hospitals and clinics segment commands the largest, accounting for an impressive 49.07%. This substantial share is primarily attributed to the high concentration of battery-powered equipment utilized within these healthcare facilities. Hospitals and clinics are critical environments where reliability and performance of medical devices are essential, and the prevalence of mobile and portable devices underscores their dependence on efficient battery solutions.
By Type
By Battery Type
By Application
By End User
By Region
Geography Breakdown